New Positive Clinical Data Supports Quest Towards Orphan Designations Seeking Alpha Article. http://seekingalpha.com/article/2569135-new-positive-clinical-data-supports-quest-towards-orphan-designations?uprof=45 Summary We view the new clinical data as highly promising. 2nd-Gen viral vector showing more controlled delivery and longer duration of effect. MDGN reveals three orphan targets, two of which could enter clinical trials in 2015. Highly Promising Trial Data with Next-Gen Vector, Orphan Indications Revealed. Q3 Results